11 August 2022 · Trastuzumab products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Hydrocortisone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Hydromorphone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Thiotepa products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
11 August 2022 · Topotecan products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
1 October 2020 · Smaller packs of licensed medicines can be produced for clinics and departments by their hospital pharmacy, under pharmacist supervision in accordance with GMP
29 February 2016 · This document is intended to cover stability testing of all oral liquid formulations including suspensions, emulsions, solutions and powders for reconstitution
16 December 2016 · The purpose of this document is to give guidance to those outsourcing PN compounding on the risks in the outsourcing and supply process and to…